# Japan Medical Oxygen Concentrators Market

> Japan Medical Oxygen Concentrators Market Research Report By Product Type (Portable Oxygen Concentrators, Stationary Oxygen Concentrators), By Technology (Continuous Flow, Pulse Dose), By Indication (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Others) and By End User (Hospitals and Clinics, Homecare Settings, Others) -Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 2.44%
- **2024:** $ 134.62 Million
- **2025:** $ 137.91 Million
- **2035:** $ 175.5 Million
- **Key Players:** Philips (NL), Invacare (US), AirSep (US), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (GB), Caire Inc. (US)

**Report ID:** MRFR/MED/49060-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/japan-medical-oxygen-concentrators-market-50817

---

## Market Summary

## **Japan Medical Oxygen Concentrators Market Overview**

As per MRFR analysis, the Japan Medical Oxygen Concentrators Market Size was estimated at 152.1 (USD Million) in 2023. The Japan Medical Oxygen Concentrators Market Industry is expected to grow from 161.55(USD Million) in 2024 to 370 (USD Million) by 2035. The Japan Medical Oxygen Concentrators Market CAGR (growth rate) is expected to be around 7.825% during the forecast period (2025 - 2035).

### **Key Japan Medical Oxygen Concentrators Market Trends Highlighted**

The Japan Medical Oxygen Concentrators Market is experiencing notable trends influenced by various market drivers. The aging population in Japan, which has one of the highest life expectancies in the world, is a significant driver for the demand for medical oxygen concentrators. As the elderly population often faces respiratory conditions, the need for home healthcare solutions, including oxygen therapy, is increasing. Additionally, the rise in chronic respiratory diseases and the impact of air pollution in urban areas are contributing to the growing adoption of oxygen concentrators.

Moreover, recent advancements in technology, such as portable and more efficient oxygen concentrators, are creating new opportunities for manufacturers.The Japanese government is actively promoting healthcare innovation, which encourages the development and distribution of advanced medical devices. Opportunities exist for companies to engage in research and development, focusing on creating devices that cater to both acute and chronic respiratory conditions. This aligns with Japan's commitment to enhancing patient care through technology. In recent times, there has been an upward trend in the acceptance of home-based oxygen therapy.

This shift reflects a broader movement towards patient-centered care, where individuals prefer receiving treatments at home rather than in clinical settings. Telehealth services are also becoming more integrated, allowing patients to receive oxygen therapy while staying connected with healthcare providers.Such trends underscore the changing landscape of healthcare in Japan, emphasizing the need for reliable and efficient medical oxygen solutions to support the well-being of patients in their homes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Japan Medical Oxygen Concentrators Market Drivers**

### **Increasing Respiratory Disorders in Japan**

One major factor propelling the Japan Medical Oxygen Concentrators Market Industry is the increase in respiratory conditions, especially chronic obstructive pulmonary disease (COPD). Over 6 million people in Japan are thought to have COPD, according to data from the Ministry of Health, Labour, and Welfare. The need for dependable oxygen treatment solutions is rising due to this expanding patient base, which is fuelling the market for medical oxygen concentrators. With more than 28% of the population 65 and over as of 2020, Japan's aging population makes this problem worse and increases the need for respiratory care and treatment.

Prominent associations like the Japan Respiratory Society are aggressively raising awareness of these conditions, which is impacting the Japan medical oxygen concentrator market's expansion.

### **Technological Advancements in Medical Devices**

Recent advancements in technology have significantly increased the efficiency and user-friendliness of medical oxygen concentrators, positively affecting the Japan Medical Oxygen Concentrators Market Industry. The introduction of portable and lightweight oxygen concentrators allows patients to maintain an active lifestyle, thereby broadening the market. The Ministry of Economy, Trade and Industry of Japan has reported an increase in patents related to oxygen concentrators, with a growth rate of approximately 15% over the last five years.This technological innovation fosters competition among manufacturers, driving product improvements and increasing market accessibility for patients in need of oxygen therapy.

### **Government Initiatives and Support for Healthcare**

The Japanese government is actively investing in healthcare initiatives aimed at improving respiratory care, which is a key driver for the Japan Medical Oxygen Concentrators Market Industry. Recent policies aimed at enhancing the delivery of home medical care have allocated significant funding to support patients using medical devices such as oxygen concentrators.

The Japan Home Healthcare Association notes that the government aims to increase the number of home healthcare services by 20% in the next five years, emphasizing the importance of portable medical devices.This governmental push not only highlights the commitment to improving patient care but also stimulates market growth for oxygen concentrators as more patients receive prescriptions for at-home oxygen therapy.

## **Japan Medical Oxygen Concentrators Market Segment Insights**

### **Medical Oxygen Concentrators Market Product Type Insights**

The Japan Medical Oxygen Concentrators Market, characterized by its diverse Product Type segment, is a key component of the broader healthcare landscape in Japan. This market is primarily divided into Portable Oxygen Concentrators and Stationary Oxygen Concentrators, each catering to unique patient needs and preferences. Portable Oxygen Concentrators have gained significant traction due to their flexibility and convenience, allowing patients to maintain mobility while receiving the necessary oxygen therapy. Japan's demographic trends indicate a growing elderly population with increasing respiratory ailments, which further emphasizes the importance of these portable devices.

They provide users the ability to live more active lifestyles, as they allow for mobility without the constraints of traditional oxygen delivery systems.On the other hand, Stationary Oxygen Concentrators remain a pivotal part of the medical oxygen delivery system, particularly for patients requiring continuous oxygen therapy in a home setting. These devices are often larger but are designed to deliver a steady supply of oxygen to patients with chronic conditions. The demand for Stationary Oxygen Concentrators is bolstered by the rising prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, among the Japanese population.

These concentrators also appeal to healthcare providers and caregivers due to their reliability and efficiency in ensuring adequate oxygen supply over long periods.Overall, the Product Type segment of the Japan Medical Oxygen Concentrators Market showcases a dynamic interplay between mobility and reliable care, reflecting changing patient lifestyles and healthcare needs. The growth drivers for this market include advancements in technology, increased awareness regarding respiratory diseases, and supportive government initiatives aimed at improving healthcare access for the aging population.

However, challenges such as regulatory hurdles and the need for awareness among patients and healthcare professionals regarding the benefits of oxygen therapy may impact market growth. The opportunities within this segment are significant, given the projected increase in demand as healthcare systems in Japan continue to adapt to the needs of a growing elderly population. The segmentation of the Japan Medical Oxygen Concentrators Market into portable and stationary products highlights the importance of tailored solutions in addressing the diverse needs of patients, further driving innovation and development in this essential healthcare segment.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Medical Oxygen Concentrators Market Technology Insights**

The Technology segment of the Japan Medical Oxygen Concentrators Market encompasses various innovations tailored to address the specific needs of patients requiring supplemental oxygen. Continuous Flow technology is a widely utilized option, recognized for its ability to deliver a steady stream of oxygen, making it especially beneficial for patients with chronic respiratory conditions. This reliability caters to users who require consistent oxygen levels throughout the day and night, enhancing their quality of life. On the other hand, Pulse Dose technology offers an advanced, on-demand dispensing of oxygen, optimizing usage and making it suitable for more active individuals.

This segment has seen an increase in demand as it allows for greater mobility and convenience for users, thus significantly impacting their daily activities. Both technologies reflect the growing trend towards personalized healthcare solutions in Japan, driven by an aging population and increasing prevalence of respiratory diseases. The improving technological advancements and a rise in healthcare infrastructure support the continuous evolution and adoption of these technologies in the market. As healthcare providers increasingly recognize the benefits of these technological advancements, they are likely to dominate the market by addressing the diverse needs of patients effectively.

### **Medical Oxygen Concentrators Market Indication Insights**

The Japan Medical Oxygen Concentrators Market focusing on the Indication segment comprises critical areas including Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, and others, reflecting the diverse healthcare needs of the population. Chronic Obstructive Pulmonary Disease significantly contributes to respiratory issues in Japan, necessitating an increased demand for oxygen therapy solutions.

Asthma, impacting a notable portion of the younger population, also drives the need for portable oxygen concentrators that facilitate mobility and enhance quality of life.Furthermore, Sleep Apnea has become increasingly recognized as a prevalent health concern, creating opportunities for advanced medical technology to monitor and treat this condition effectively. The 'Others' category encompasses various less prevalent conditions but still presents substantial demand for oxygen therapy due to an aging population and rising respiratory problems in Japan.

Overall, the shift towards home healthcare solutions, driven by a growing elderly demographic, alongside advancements in technology and increasing awareness of respiratory diseases, positions the Japan Medical Oxygen Concentrators Market favorably for significant expansion in this segment.

### **Medical Oxygen Concentrators Market End User Insights**

The End User segment of the Japan Medical Oxygen Concentrators Market plays a crucial role in providing essential respiratory support. Hospitals and Clinics have traditionally dominated this segment, being primary providers of oxygen therapy, as they cater to patients with severe respiratory conditions. The rising number of patients affected by chronic obstructive pulmonary disease (COPD) and other respiratory ailments has significantly increased demand in these facilities. Homecare Settings have emerged as a significant aspect of this market, reflecting a shift towards outpatient care and the preference for at-home treatment due to convenience and comfort.

This change is driven by technological advancements in medical devices, enabling patients to use oxygen concentrators easily at home. The Others category, which includes rehabilitation centers and long-term care facilities, is gradually growing as these institutions recognize the importance of providing continuous oxygen therapy to improve overall patient outcomes. Overall, each category within the End User segment contributes to the expanding landscape of the Japan Medical Oxygen Concentrators Market, highlighting the important intersection of healthcare delivery and technological progress in the region.

### **Japan Medical Oxygen Concentrators Market Key Players and Competitive Insights**

The Japan Medical Oxygen Concentrators Market displays a dynamic competitive landscape characterized by several key players striving to establish their foothold and gain market share in an evolving healthcare ecosystem. This market is driven by an increasing prevalence of respiratory diseases and an aging population that requires enhanced respiratory care solutions. Competitors in this space are focused on innovative product offerings, technological advancements, and strategic collaborations to enhance their operational capabilities. The market is also influenced by the regulatory environment, which mandates high standards for the quality and safety of medical devices.

As stakeholders navigate these challenges and opportunities, they continuously assess their competitive positioning to cater to the growing demand for efficient and reliable oxygen therapy solutions.DeVilbiss Healthcare stands out in the Japan Medical Oxygen Concentrators Market with a focus on high-quality products that cater specifically to the needs of patients requiring respiratory aids. The company is recognized for its commitment to innovation, crafting devices that not only enhance patient comfort but also ensure adherence to stringent regulatory standards in Japan.

The brand's reputation is built upon a portfolio that includes portable and stationary oxygen concentrators designed to provide reliable oxygen delivery in various healthcare settings. DeVilbiss Healthcare's strategic partnerships and robust distribution networks in Japan further bolster its market presence, allowing for effective outreach to healthcare providers and institutions that prioritize patient-centered care.Welch Allyn, while known for a diverse range of medical equipment, also plays a significant role in the Japan Medical Oxygen Concentrators Market. The company's oxygen concentrators are designed to meet the varying demands of both clinical and home care environments, showcasing innovative designs and user-friendly features.

Welch Allyn’s strengths include a strong brand reputation and a commitment to quality, which resonate well with healthcare professionals in Japan. Their market presence is reinforced through collaborations and mergers that expand their product offerings and improve service delivery. Welch Allyn continues to focus on optimizing patient outcomes by providing effective medical solutions, leveraging its global expertise to cater specifically to the nuances of the Japanese healthcare landscape.

Key products include advanced oxygen concentrator models paired with high-level customer support and training programs aimed at ensuring optimal usage and maintenance, which reflects the company's dedication to enhancing the overall patient experience in Japan.

### **Key Companies in the Japan Medical Oxygen Concentrators Market Include**

- [DeVilbiss Healthcare](https://drivedevilbiss.com/en/products/respiratory/oxygen-therapy/cat/oxygen%20concentrators)
- Welch Allyn
- GCE Group
- Nidek Medical Products
- Fisher and Paykel Healthcare
- Philips
- Linde Healthcare
- Invacare
- Drive DeVilbiss Healthcare
- BPM Medical
- Caire Inc.
- OMRON
- AirSep
- Breas Medical

## **Japan Medical Oxygen Concentrators Market Industry Developments**

The Japan Medical Oxygen Concentrators Market has seen significant developments recently, particularly driven by the increasing demand for respiratory support devices due to aging populations and respiratory illnesses. In August 2023, Philips announced advancements in their oxygen concentrators, aiming to enhance patient outcomes and usability. Similarly, in September 2023, Invacare and DeVilbiss Healthcare have been expanding their distribution networks across Japan to cater to the surging demand within the country. Notably, in July 2023, GCE Group obtained necessary approvals for a new line of portable oxygen concentrators, thereby marking its expansion in Japanese healthcare.

In terms of mergers and acquisitions, Linde Healthcare completed the acquisition of a local competitor, significantly bolstering its market share in March 2023, focusing on innovative medical gases and oxygen solutions. The market valuation of companies like Fisher and Paykel Healthcare and AirSep is also on the rise due to innovative products and increased awareness of home healthcare solutions, aligning with Japan's strategic healthcare initiatives from the Ministry of Health, Labour and Welfare. These factors are collectively driving growth in the Medical Oxygen Concentrators Market in Japan.

## **Japan Medical Oxygen Concentrators Market Segmentation Insights**

### **Medical Oxygen Concentrators Market Product Type****Outlook**

- Portable Oxygen Concentrators
- Stationary Oxygen Concentrators

### **Medical Oxygen Concentrators Market Technology****Outlook**

- Continuous Flow
- Pulse Dose

### **Medical Oxygen Concentrators Market Indication****Outlook**

- Chronic Obstructive Pulmonary Disease
- Asthma
- Sleep Apnea
- Others

### **Medical Oxygen Concentrators Market End User****Outlook**

- Hospitals and Clinics
- Homecare Settings
- Others

## Market Drivers

### Rising Healthcare Expenditure

The upward trend in healthcare expenditure in Japan is a crucial driver for the medical oxygen-concentrators market. With the government and private sectors investing more in healthcare services, there is a corresponding increase in the availability of advanced medical devices. In recent years, healthcare spending has risen by approximately 4% annually, reflecting a commitment to improving patient care. This increase in funding allows for the procurement of high-quality oxygen concentrators, which are essential for effective respiratory management. As healthcare facilities expand their services and capabilities, the medical oxygen-concentrators market is likely to benefit from this financial support. Furthermore, as patients demand better quality care, the market is expected to grow, driven by the need for reliable and efficient oxygen delivery systems.

### Government Initiatives and Funding

Government initiatives aimed at improving healthcare infrastructure are a significant driver for the medical oxygen-concentrators market. In Japan, the government has been actively promoting policies that enhance access to medical devices, including oxygen concentrators. Recent funding programs have been established to support hospitals and clinics in acquiring advanced medical equipment, thereby increasing the availability of oxygen therapy solutions. This support is crucial, especially in rural areas where access to healthcare services may be limited. The medical oxygen-concentrators market stands to benefit from these initiatives, as they not only facilitate the procurement of necessary equipment but also raise awareness about the importance of oxygen therapy in managing respiratory conditions. Consequently, the market is expected to experience growth as healthcare facilities expand their capabilities.

### Increased Awareness of Home Healthcare

The growing awareness of home healthcare solutions is driving the medical oxygen-concentrators market in Japan. As patients and families become more informed about the benefits of receiving care at home, the demand for home-based oxygen therapy is rising. This shift is particularly relevant for elderly patients who prefer to manage their health conditions in a familiar environment. The medical oxygen-concentrators market is likely to see an increase in sales as more individuals opt for home healthcare services. Additionally, the convenience and cost-effectiveness of home oxygen therapy are appealing factors for both patients and healthcare providers. As a result, the market is poised for growth, reflecting a broader trend towards patient-centered care that prioritizes comfort and accessibility.

### Rising Prevalence of Respiratory Disorders

The increasing incidence of respiratory disorders in Japan is a pivotal driver for the medical oxygen-concentrators market. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, necessitating the need for supplemental oxygen. According to recent health statistics, approximately 3.5 million individuals in Japan are diagnosed with COPD, which underscores the demand for effective oxygen therapy solutions. This trend is likely to propel the market forward, as healthcare providers seek to offer patients reliable and efficient oxygen delivery systems. Furthermore, the aging population, which is more susceptible to respiratory ailments, further amplifies this demand. As a result, The market for medical oxygen concentrators is expected to witness substantial growth, driven by the urgent need for effective management of these chronic conditions.

### Technological Innovations in Oxygen Delivery

Technological advancements in oxygen delivery systems are significantly influencing the medical oxygen-concentrators market. Innovations such as portable and lightweight concentrators are enhancing patient mobility and comfort, making oxygen therapy more accessible. The introduction of smart concentrators equipped with connectivity features allows for remote monitoring and management, which is particularly beneficial for elderly patients living independently. In Japan, the market for these advanced devices is projected to grow at a CAGR of around 8% over the next five years. This growth is indicative of a broader trend towards personalized healthcare solutions, where technology plays a crucial role in improving patient outcomes. As manufacturers continue to invest in research and development, the medical oxygen-concentrators market is likely to expand, driven by the demand for more efficient and user-friendly devices.

## Future Outlook

The [Medical Oxygen Concentrators Market](https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876) is projected to grow at a 2.44% CAGR from 2025 to 2035, driven by increasing respiratory diseases and aging population.

**New opportunities:**

- Development of portable oxygen concentrators for home use
- Integration of telehealth services for remote monitoring
- Expansion into rural healthcare facilities with tailored solutions

By 2035, the market is expected to achieve robust growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Product Type: Portable Oxygen Concentrators (Largest) vs. Stationary Oxygen Concentrators (Fastest-Growing)

In the Japan medical oxygen-concentrators market, Portable Oxygen Concentrators command the largest market share due to their convenience and adaptability for patients needing oxygen therapy on the go. These devices cater to an increasingly mobile population, allowing for better quality of life. Conversely, Stationary Oxygen Concentrators hold a significant portion but are primarily favored by patients with more complex health requirements, leading to varied distribution across different consumer demographics.

The growth trends in this market indicate a rising demand for Portable Oxygen Concentrators, driven by advancements in technology that enhance performance and reduce size. This segment is anticipated to grow as healthcare professionals promote outpatient care and home-based oxygen therapy. Stationary units, while slower growing, benefit from continuous innovations aimed at improving efficiency and ease of use, appealing to a steady market segment of chronic patients.

Portable Oxygen Concentrators (Dominant) vs. Stationary Oxygen Concentrators (Emerging)

Portable Oxygen Concentrators represent the dominant category in the Japan medical oxygen-concentrators market, characterized by their lightweight and portability, making them ideal for active patients. They are often equipped with features such as adjustable flow rates and long battery life, which enhance their usability. On the other hand, Stationary Oxygen Concentrators, identified as an emerging category, are designed for prolonged use at home, offering high output and low operational costs. However, the rising inclination towards mobility among patients is positioning Portable units as the preferred choice. Both categories are experiencing technological advancements, but Portable units currently hold a significant edge in market share, reflecting a shift in consumer preferences towards more adaptable solutions.

### By Technology: Continuous Flow (Largest) vs. Pulse Dose (Fastest-Growing)

In the Japan medical oxygen-concentrators market, the segment distribution showcases Continuous Flow technology as the largest contributor, commanding a significant portion of market share. This segment benefits from widespread acceptance among patients requiring constant oxygen supply, making it a preferred choice for home healthcare settings. Conversely, Pulse Dose technology is emerging rapidly, appealing to patients needing more mobility and adaptability in their oxygen therapy, thus capturing an increasing share of the market.

The growth trends in this segment are driven by advancements in technology and increased awareness of home healthcare. Continuous Flow remains strong due to its reliability and consistent oxygen delivery, while the Pulse Dose segment is gaining momentum thanks to innovations that enable portable solutions. Factors such as aging demographics and a shift towards personalized medicine also support the rise of these technologies, intensifying competition within the market.

Technology: Continuous Flow (Dominant) vs. Pulse Dose (Emerging)

Continuous Flow technology is characterized by its ability to provide a steady stream of oxygen, making it particularly suitable for patients who require uninterrupted therapy. Its dominance in the market stems from its effectiveness, reliability, and simplicity, appealing mainly to elderly patients and those with severe respiratory conditions. On the other hand, Pulse Dose technology represents a more recent innovation, designed for patients who value mobility. This segment efficiently delivers oxygen in bursts, allowing users to engage in daily activities without the burden of conventional equipment. As such, Pulse Dose is quickly becoming an attractive alternative, especially among younger, more active patients, driving growth and market diversification.

### By Indication: Chronic Obstructive Pulmonary Disease (Largest) vs. Asthma (Fastest-Growing)

In the Japan medical oxygen-concentrators market, Chronic Obstructive Pulmonary Disease (COPD) accounts for the largest share among indication segments due to its prevalence in the aging population. Asthma follows as a significant segment, while Sleep Apnea and others represent smaller portions of the market. Together, these segments reflect the increasing demand for oxygen therapy solutions in treating various respiratory conditions.

The growth trends indicate a robust expansion of the asthma segment, largely driven by increased awareness and diagnosis rates. Meanwhile, COPD continues to dominate due to its chronic nature and long-term management needs. Factors such as the rising geriatric population, environmental pollution, and lifestyle changes contribute to the growing need for effective oxygen therapy solutions across these segments.

Chronic Obstructive Pulmonary Disease (Dominant) vs. Asthma (Emerging)

Chronic Obstructive Pulmonary Disease (COPD) remains the dominant indication in the Japan medical oxygen-concentrators market, characterized by a significant patient base requiring long-term oxygen therapy. Its widespread prevalence among older adults necessitates continuous innovations in oxygen delivery systems, making it a priority for manufacturers. In contrast, the asthma segment is emerging as a rapidly growing area due to improved awareness and early diagnosis, prompting patients to seek portable and effective oxygen solutions. This dual focus enables healthcare providers to cater to diverse patient needs, thereby enhancing market competition and innovation. As both segments evolve, they reflect changing healthcare dynamics and patient preferences for personalized care.

### By End User: Homecare Settings (Largest) vs. Hospitals and Clinics (Fastest-Growing)

In the Japan medical oxygen-concentrators market, the distribution between end-user segments reveals that homecare settings hold the largest market share. This segment is preferred due to the rising aging population and an increased focus on home healthcare solutions, making it essential in the landscape. Conversely, hospitals and clinics are emerging as the fastest-growing segment, driven by advancements in healthcare infrastructure and the increasing number of patients requiring acute care.

The growth trends indicate a shift towards home-based therapies, which align with patient preferences for receiving care in familiar environments. The demand for portable oxygen concentrators is surging, facilitating greater independence for patients. Moreover, hospitals and clinics are expanding their facilities and capabilities, leading to a rising need for efficient oxygen delivery systems, which in turn propels the growth of this segment.

Homecare Settings (Dominant) vs. Hospitals and Clinics (Emerging)

Homecare settings emerge as the dominant segment in the Japan medical oxygen-concentrators market, characterized by a strong demand driven by an aging demographic that favors at-home care solutions. This segment is particularly marked by the adoption of portable and compact oxygen concentrators, providing patients flexibility and ease of use. The increasing awareness of chronic respiratory diseases further supports this trend, as more individuals opt for home treatment options. On the other hand, hospitals and clinics represent an emerging segment, poised for growth due to investments in healthcare facilities and enhanced patient care technologies. The demand for high-capacity oxygen concentrators within these institutions is on the rise, reflecting the need for effective respiratory therapy solutions in clinical settings.

## Competitive Benchmarking

The medical oxygen-concentrators market in Japan is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on enhancing patient care. Key players such as Philips (NL), Invacare (US), and Nidek Medical (JP) are actively pursuing strategies that emphasize technological advancements and regional expansion. Philips (NL) has positioned itself as a leader in the market by investing heavily in research and development, particularly in portable oxygen solutions that cater to the growing demand for home healthcare. Meanwhile, Invacare (US) focuses on diversifying its product offerings and enhancing its distribution channels to capture a larger market share, while Nidek Medical (JP) leverages its local expertise to tailor products specifically for the Japanese consumer, thereby strengthening its competitive edge.
The business tactics employed by these companies reflect a market structure that is moderately fragmented, with several players vying for dominance. Localizing manufacturing and optimizing supply chains are critical strategies that enhance operational efficiency and reduce costs. This competitive environment is further influenced by the collective actions of these key players, who are not only competing on product quality but also on service delivery and customer engagement.
In October 2025, Philips (NL) announced the launch of a new line of portable oxygen concentrators designed specifically for the Japanese market. This strategic move is significant as it aligns with the increasing demand for mobility and independence among patients requiring oxygen therapy. By introducing products that cater to local needs, Philips (NL) is likely to enhance its market presence and customer loyalty.
In September 2025, Invacare (US) expanded its distribution network in Japan by partnering with local healthcare providers. This collaboration is expected to improve access to their products and services, thereby increasing market penetration. Such strategic alliances not only facilitate better service delivery but also enhance brand visibility in a competitive landscape.
In August 2025, Nidek Medical (JP) launched an innovative telehealth platform that integrates with its oxygen concentrators, allowing for real-time monitoring of patients' oxygen levels. This initiative reflects a growing trend towards digital health solutions and positions Nidek Medical (JP) as a forward-thinking player in the market. The integration of technology into healthcare products is likely to enhance patient outcomes and satisfaction.
As of November 2025, the competitive trends in the medical oxygen-concentrators market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing product offerings and market reach. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of not only meeting current market demands but also anticipating future needs in a rapidly changing healthcare landscape.

## Recent News & Developments

The Japan Medical Oxygen Concentrators Market has seen significant developments recently, particularly driven by the increasing demand for respiratory support devices due to aging populations and respiratory illnesses. In August 2023, Philips announced advancements in their oxygen concentrators, aiming to enhance patient outcomes and usability. Similarly, in September 2023, Invacare and DeVilbiss Healthcare have been expanding their distribution networks across Japan to cater to the surging demand within the country. Notably, in July 2023, GCE Group obtained necessary approvals for a new line of portable oxygen concentrators, thereby marking its expansion in Japanese healthcare.

In terms of mergers and acquisitions, Linde Healthcare completed the acquisition of a local competitor, significantly bolstering its market share in March 2023, focusing on innovative medical gases and oxygen solutions. The market valuation of companies like Fisher and Paykel Healthcare and AirSep is also on the rise due to innovative products and increased awareness of home healthcare solutions, aligning with Japan's strategic healthcare initiatives from the Ministry of Health, Labour and Welfare. These factors are collectively driving growth in the Medical Oxygen Concentrators Market in Japan.

## Report Scope

| MARKET SIZE 2024 | 134.62(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 137.91(USD Million) |
| MARKET SIZE 2035 | 175.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.44% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Philips (NL), Invacare (US), AirSep (US), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (GB), Caire Inc. (US) |
| Segments Covered | Product Type, Technology, Indication, End User |
| Key Market Opportunities | Advancements in portable medical oxygen-concentrators enhance accessibility for patients in remote areas. |
| Key Market Dynamics | Rising demand for home healthcare drives innovation and competition in the medical oxygen-concentrators market. |
| Countries Covered | Japan |

## Frequently Asked Questions

**Q: What is the current valuation of the medical oxygen-concentrators market in Japan as of 2024?**
A: The market valuation was $134.62 Million in 2024.

**Q: What is the projected market valuation for the medical oxygen-concentrators market in Japan by 2035?**
A: The projected valuation for 2035 is $175.5 Million.

**Q: What is the expected CAGR for the medical oxygen-concentrators market in Japan during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 2.44%.

**Q: Which product types dominate the medical oxygen-concentrators market in Japan?**
A: The market includes Portable Oxygen Concentrators valued at $65.0 Million and Stationary Oxygen Concentrators valued at $110.5 Million.

**Q: What technologies are utilized in the medical oxygen-concentrators market in Japan?**
A: The market features Continuous Flow technology valued at $105.0 Million and Pulse Dose technology valued at $70.5 Million.

**Q: What are the primary indications for medical oxygen-concentrators in Japan?**
A: Key indications include Chronic Obstructive Pulmonary Disease (COPD) at $65.0 Million, Asthma at $40.0 Million, and Sleep Apnea at $35.0 Million.

**Q: Who are the key players in the medical oxygen-concentrators market in Japan?**
A: Key players include Philips, Invacare, AirSep, OxyGo, Drive DeVilbiss Healthcare, Nidek Medical, GCE Group, and Caire Inc.

**Q: What are the main end-user segments for medical oxygen-concentrators in Japan?**
A: The main end-user segments are Hospitals and Clinics, and Homecare Settings, each valued at $80.0 Million.

**Q: How does the market for medical oxygen-concentrators in Japan compare between 2024 and 2035?**
A: The market is expected to grow from $134.62 Million in 2024 to $175.5 Million in 2035.

**Q: What factors might influence the growth of the medical oxygen-concentrators market in Japan?**
A: Factors include advancements in technology, increasing prevalence of respiratory diseases, and a growing aging population.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/japan-medical-oxygen-concentrators-market-50817*